US drug spending

Cell and gene therapy Drugs: Medicare Part D Spending

What Medicare Part D spent on the medicines used for this topic, how many people used them, and the cost per unit.

Each number has its full source under its own list below.

Medicare Part D spending

1 medicines (calendar year 2024). Medicines whose FDA label lists a use on this topic, by what Part D spent on them in total. Many medicines have more than one use, so the totals are not added up.

At the source
  1. 1PlerixaforPlerixafor · $862.33 per unit$408,842

Source: Centers for Medicare & Medicaid Services, Medicare Part D Spending by Drug, calendar year 2024. Retrieved 12 Nov 2026.

Market reports on cell and gene therapy

Search all
Pharmaceuticals

AAV Gene Therapy

Worldwide · 2024–2034

View report Pharmaceuticals

Allogeneic Cell Therapy

Worldwide · 2024–2034

View report Pharmaceuticals

CAR-T Cell Therapy

Worldwide · 2024–2034

View report Pharmaceuticals

Cell and Gene Therapy CDMO

Worldwide · 2024–2034

View report Pharmaceuticals

Cell Therapy Manufacturing

Worldwide · 2024–2034

View report Pharmaceuticals

Gene Editing

Worldwide · 2024–2034

View report

US drug spending on related topics

All topics

Acuitas market sizes and forecasts are only in our full reports. How we use public data.